BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Beger RD, Schmidt MA, Kaddurah-Daouk R. Current Concepts in Pharmacometabolomics, Biomarker Discovery, and Precision Medicine. Metabolites 2020;10:E129. [PMID: 32230776 DOI: 10.3390/metabo10040129] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Schmidt JC, Dougherty BV, Beger RD, Jones DP, Schmidt MA, Mattes WB. Metabolomics as a Truly Translational Tool for Precision Medicine. Int J Toxicol 2021;40:413-26. [PMID: 34514887 DOI: 10.1177/10915818211039436] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Diray-Arce J, Conti MG, Petrova B, Kanarek N, Angelidou A, Levy O. Integrative Metabolomics to Identify Molecular Signatures of Responses to Vaccines and Infections. Metabolites 2020;10:E492. [PMID: 33266347 DOI: 10.3390/metabo10120492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zafonte RD, Wang L, Arbelaez CA, Dennison R, Teng YD. Medical Gas Therapy for Tissue, Organ, and CNS Protection: A Systematic Review of Effects, Mechanisms, and Challenges. Adv Sci (Weinh) 2022;:e2104136. [PMID: 35243825 DOI: 10.1002/advs.202104136] [Reference Citation Analysis]
4 Kachroo P, Sordillo JE, Lutz SM, Weiss ST, Kelly RS, McGeachie MJ, Wu AC, Lasky-Su JA. Pharmaco-Metabolomics of Inhaled Corticosteroid Response in Individuals with Asthma. J Pers Med 2021;11:1148. [PMID: 34834499 DOI: 10.3390/jpm11111148] [Reference Citation Analysis]
5 Yagishita Y, Gatbonton-Schwager TN, McCallum ML, Kensler TW. Current Landscape of NRF2 Biomarkers in Clinical Trials. Antioxidants (Basel) 2020;9:E716. [PMID: 32784785 DOI: 10.3390/antiox9080716] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Tolstikov V, Moser AJ, Sarangarajan R, Narain NR, Kiebish MA. Current Status of Metabolomic Biomarker Discovery: Impact of Study Design and Demographic Characteristics. Metabolites 2020;10:E224. [PMID: 32485899 DOI: 10.3390/metabo10060224] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Gómez-Cebrián N, Vázquez Ferreiro P, Carrera Hueso FJ, Poveda Andrés JL, Puchades-Carrasco L, Pineda-Lucena A. Pharmacometabolomics by NMR in Oncology: A Systematic Review. Pharmaceuticals (Basel) 2021;14:1015. [PMID: 34681239 DOI: 10.3390/ph14101015] [Reference Citation Analysis]
8 Srivastava N, Sarethy IP, Jeevanandam J, Danquah M. Emerging strategies for microbial screening of novel chemotherapeutics. Journal of Molecular Structure 2022;1255:132419. [DOI: 10.1016/j.molstruc.2022.132419] [Reference Citation Analysis]
9 Kim HW. Metabolomic Approaches to Investigate the Effect of Metformin: An Overview. Int J Mol Sci 2021;22:10275. [PMID: 34638615 DOI: 10.3390/ijms221910275] [Reference Citation Analysis]
10 Ghosh R, Bu G, Nannenga BL, Sumner LW. Recent Developments Toward Integrated Metabolomics Technologies (UHPLC-MS-SPE-NMR and MicroED) for Higher-Throughput Confident Metabolite Identifications. Front Mol Biosci 2021;8:720955. [PMID: 34540897 DOI: 10.3389/fmolb.2021.720955] [Reference Citation Analysis]
11 Carlos Alarcon-Barrera J, Kostidis S, Ondo-Mendez A, Giera M. Recent advances in metabolomics analysis for early drug development. Drug Discov Today 2022:S1359-6446(22)00076-9. [PMID: 35218927 DOI: 10.1016/j.drudis.2022.02.018] [Reference Citation Analysis]
12 Zagotto G, Bortoli M. Drug Design: Where We Are and Future Prospects. Molecules 2021;26:7061. [PMID: 34834152 DOI: 10.3390/molecules26227061] [Reference Citation Analysis]
13 Balcerczyk A, Damblon C, Elena-Herrmann B, Panthu B, Rautureau GJP. Metabolomic Approaches to Study Chemical Exposure-Related Metabolism Alterations in Mammalian Cell Cultures. Int J Mol Sci 2020;21:E6843. [PMID: 32961865 DOI: 10.3390/ijms21186843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Molloy B, Mullin L, King A, Gethings LA, Plumb RS, Wilson ID. The Pharmacometabodynamics of Gefitinib after Intravenous Administration to Mice: A Preliminary UPLC-IM-MS Study. Metabolites 2021;11:379. [PMID: 34208076 DOI: 10.3390/metabo11060379] [Reference Citation Analysis]
15 Saigusa D, Matsukawa N, Hishinuma E, Koshiba S. Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics. Drug Metab Pharmacokinet 2021;37:100373. [PMID: 33631535 DOI: 10.1016/j.dmpk.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
16 Tounta V, Liu Y, Cheyne A, Larrouy-Maumus G. Metabolomics in infectious diseases and drug discovery. Mol Omics 2021;17:376-93. [PMID: 34125125 DOI: 10.1039/d1mo00017a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Amaro F, Carvalho M, Bastos MDL, Guedes de Pinho P, Pinto J. Pharmacometabolomics Applied to Personalized Medicine in Urological Cancers. Pharmaceuticals 2022;15:295. [DOI: 10.3390/ph15030295] [Reference Citation Analysis]
18 Sakallioglu IT, Barletta RG, Dussault PH, Powers R. Deciphering the mechanism of action of antitubercular compounds with metabolomics. Comput Struct Biotechnol J 2021;19:4284-99. [PMID: 34429848 DOI: 10.1016/j.csbj.2021.07.034] [Reference Citation Analysis]
19 Letertre MPM, Giraudeau P, de Tullio P. Nuclear Magnetic Resonance Spectroscopy in Clinical Metabolomics and Personalized Medicine: Current Challenges and Perspectives. Front Mol Biosci 2021;8:698337. [PMID: 34616770 DOI: 10.3389/fmolb.2021.698337] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]